Relationship Between Pemphigus Vulgaris Severity and PCR-positive Herpes Simplex Virus


  • Sharon Baum Department of Dermatology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
  • Itai Atar
  • Dan Coster
  • Sara Dovrat
  • Michal Solomon
  • Eli Sprecher
  • Tal Zeeli
  • Aviv Barzilai



pemphigus vulgaris, herpes simplex, disease exacerbation, acyclovir


Pemphigus vulgaris is a rare autoimmune skin disease. Although herpes simplex virus has been associated with autoimmune diseases, evidence regarding its association with pemphigus vulgaris exacerbations is scarce. This retrospective cohort study aimed to characterize the epidemiological and clinical features of patients with pemphigus vulgaris who were herpes simplex-positive, compared with those who were herpes simplex-negative, during disease onset. Of 62 patients with pemphigus vulgaris who underwent PCR testing for herpes simplex virus, 25 (40.3%) were positive, with a mean age of 56.1 ± 15.5 years; 35.5% were male. The herpes-positive group had significantly elevated levels of C-reactive protein, Pemphigus Disease Activity Index score, and shorter time to relapse. The time to remission, number of exacerbations per year, and remission status were non-significantly elevated in the herpes-positive group. Thus, routine testing lesions from patients with pemphigus for herpes simplex virus should be performed. If positive, antiviral treatment should be initiated; and preventive antiviral treatment should be considered in severe cases.


Download data is not yet available.


Kridin K. Pemphigus group: overview, epidemiology, mortality, and comorbidities. Immunol Res 2018; 66: 255-270. DOI:

Kayani M, Aslam AM. Bullous pemphigoid and pemphigus vulgaris. BMJ 2017; 357. DOI:

Bystryn JC, Rudolph JL. Pemphigus. Lancet 2005; 366: 61-73. DOI:

Lever WF, Hashimoto K. The etiology and treatment of pemphigus and pemphigoid. J Invest Dermatol 1969; 53: 373-389. DOI:

Hammers CM, Stanley JR. Mechanisms of disease: pemphigus and bullous pemphigoid. Annu Rev Pathol 2016; 11: 175-197. DOI:

Stanley JR, Amagai M. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 2006; 355: 1800-1810. DOI:

Brenner S, Sasson A, Sharon O. Pemphigus and infections. Clin Dermatol 2002; 20: 114-118. DOI:

Ruocco E, Ruocco V, Lo Schiavo A, Brunetti G, Wolf R. Viruses and pemphigus: an intriguing never-ending story. Dermatology 2014; 229: 310-315. DOI:

Brandão ML, Fernandes NC, Batista DP, Santos N. Refractory pemphigus vulgaris associated with herpes infection: case report and review. Rev Inst Med Trop Sao Paulo 2011; 53: 113-117. DOI:

Armangue T, Moris G, Cantarín-Extremera V, Conde CE, Rostasy K, Erro ME, et al. Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology 2015; 85: 1736-1743. DOI:

Mohammadi F, Khalili Z, Mahdi Marashi S, Ehsani A, Daneshpazhooh M, Teymoori-Rad M, et al. The potential roles of herpesvirus and cytomegalovirus in the exacerbation of pemphigus vulgaris. Dermatol Pract Concept 2018; 8: 262-271. DOI:

Machado AR da SR, La Serra L, Turatti A, Machado AM, Roselino AM. Herpes simplex virus 1 and cytomegalovirus are associated with pemphigus vulgaris but not with pemphigus foliaceus disease. Exp Dermatol 2017; 26: 966-968. DOI:

Grover S. Scoring systems in pemphigus. Ind J Dermatol 2011; 56: 145-149. DOI:

Murrell DF, Peña S, Joly P, Marinovic B, Hashimoto T, Diaz LA, et al. Diagnosis and management of pemphigus: recommendations of an international panel of experts. J Am Acad Dermatol 2020; 82: 575-585. DOI:

Murrell DF, Dick S, Ahmed AR, Amagai M, Barnadas MA, Borradori L, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol 2008; 58: 1043-1046. DOI:

Filén F, Strand A, Allard A, Blomberg J, Herrmann B. Duplex real-time polymerase chain reaction assay for detection and quantification of herpes simplex virus type 1 and herpes simplex virus type 2 in genital and cutaneous lesions. Sex Transm Dis 2004; 31: 331-336. DOI:

Centers for Disease Control and Prevention. Sexually transmitted infections treatement guidelines, 2021. Available from:

Ercolini AM, Miller SD. The role of infections in autoimmune disease. Clin Exp Immunol 2009; 155: 1-15. DOI:

Vega-Memíje ME, García-Vázquez FJ, Cuevas-González JC, Rodríguez-Lobato E, Aguilar-Urbano MA. Is there a causal relationship between HSV-1 and pemphigus vulgaris? Springerplus 2015; 4: 811. DOI:

Lucchese A. From HSV infection to erythema multiforme through autoimmune crossreactivity. Autoimmun Rev 2018; 17: 576-581. DOI:

Esmaili N, Hallaji Z, Abedini R, Soori T, Mortazavi H, Chams-Davatchi C. Pemphigus vulgaris and herpesviruses: Is there any relationship? Int J Dermatol 2010; 49: 1261-1265. DOI:

Konda D, Chandrashekar L, Dhodapkar R, Ganesh RN, Thappa DM. Clinical markers of herpes simplex virus infection in patients with pemphigus vulgaris. J Am Acad Dermatol (accessed 2019 Jun 10). Available from: DOI:

Kridin K, Zelber-Sagi S, Bergman R. Pemphigus vulgaris and pemphigus foliaceus: differences in epidemiology and mortality. Acta Derm Venereol 2017; 97: 1095-1099. DOI:

Kurata M, Mizukawa Y, Aoyama Y, Shiohara T. Herpes simplex virus reactivation as a trigger of mucous lesions in pemphigus vulgaris. Br J Dermatol 2014; 171: 554-560. DOI:

Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, et al. HSV shedding. Antiviral Res 2004; 63: S19-S26. DOI:

Miller CS, Danaher RJ. Asymptomatic shedding of herpes simplex virus (HSV) in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105: 43-50. DOI:

Mertz GJ. Asymptomatic shedding of herpes simplex virus 1 and 2: implications for prevention of transmission. J Infect Dis 2008; 198: 1098-1100. DOI:

Chiu HY, Chang CY, Hsiao CH, Wang LF. Concurrent cytomegalovirus and herpes simplex virus infection in pemphigus vulgaris treated with rituximab and prednisolone. Acta Derm Venereol 2013; 93: 200-201. DOI:

Atzmony L, Hodak E, Leshem YA, Rosenbaum O, Gdalevich M, Anhalt GJ, et al. The role of adjuvant therapy in pemphigus: a systematic review and meta-analysis. J Am Acad Dermatol 2015; 73: 264-271. DOI:

Didona D, Maglie R, Eming R, Hertl M. Pemphigus: current and future therapeutic strategies. Front Immunol 2019; 10: 1418. DOI:

Joly P, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, et al. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial. Lancet 2017; 389: 2031-2040. DOI:

Kumar S, De D, Handa S, Ratho RK, Bhandari S, Pal A, et al. Identification of factors associated with treatment refractoriness of oral lesions in pemphigus vulgaris. Br J Dermatol 2017; 177: 1583-1589. DOI:

Kalra A, Ratho RK, Kaur I, Kumar B. Role of herpes simplex and cytomegalo viruses in recalcitrant oral lesions of pemphigus vulgaris. Int J Dermatol 2005; 44: 259-260. DOI:



How to Cite

Baum, S., Atar, I., Coster, D., Dovrat, S., Solomon, M., Sprecher, E., Zeeli, T., & Barzilai, A. (2022). Relationship Between Pemphigus Vulgaris Severity and PCR-positive Herpes Simplex Virus. Acta Dermato-Venereologica, 102, adv00703.

Most read articles by the same author(s)

1 2 > >>